Charles River Associates’ (CRA) Global Life Sciences Practice Launches Data Analytics Platform

Charles River Associates (NASDAQ: CRAI), a worldwide leader in providing economic, financial, and management consulting services, today announced the launch of the Company’s new data analytics suite, the Healthcare Claims Analytics Platform (HCAP), at the World Orphan Drug Congress USA 2022 in Boston. Developed by CRA’s Life Sciences Practice, HCAP is a modular, dynamic, data-visualization tool that provides streamlined analysis of patient, Health Care Practitioner (HCP), and Health Care Organization (HCO) data to support insight generation and decision-making.

“The development and launch of HCAP is an exciting achievement for CRA and reflects our commitment to generating value through innovation,” said CRA’s President and Chief Executive Officer Paul Maleh. “For more than 25 years, life science companies, law firms, and regulatory agencies around the globe have turned to CRA when they need clarity and solutions to the industry’s most complex issues. Clients value our deep industry knowledge, rigorous analytic techniques, and decades of hands-on experience spanning thousands of successful engagements. I’d like to congratulate the HCAP team, led by Eddie Li, Travis Ruch, Birnur Ozbas-Erdem and Jing Li, for their dedicated work on this project. I look forward to further advancements from our Analytics team.”

“HCAP delivers the power of machine learning and patient analytics to inform market understanding and support intelligent decision-making,” said CRA’s Life Sciences Practice Leader and Vice President, Gregory K. Bell. “Our Analytics team spent a year and a half developing the interface, which is compatible with a variety of data sources and can be customized for client needs. With HCAP, clients can develop insights that inform strategic decisions and key business operations across therapeutic and geographic markets.”

HCAP can support clients in visualizing advanced analytics by providing intelligence on patients, physicians, hospitals, and the broader healthcare market. HCAP also offers a clinical trial module to bolster recruitment and resource-prioritization strategies through the identification of key providers and centers in patient treatment and care.

About CRA's Life Sciences Practice
The CRA Life Sciences Practice works with leading biotech, medical device, and pharmaceutical companies; law firms; regulatory agencies; and national and international industry associations. We provide the analytical expertise and industry experience needed to address our clients’ toughest issues. We have a reputation for rigorous and innovative analysis, careful attention to detail, and the ability to work effectively as part of a wider team of advisers.